These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 18563491)

  • 1. Suberoyl bishydroxamic acid activates notch1 signaling and suppresses tumor progression in an animal model of medullary thyroid carcinoma.
    Ning L; Jaskula-Sztul R; Kunnimalaiyaan M; Chen H
    Ann Surg Oncol; 2008 Sep; 15(9):2600-5. PubMed ID: 18563491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suberoyl bis-hydroxamic acid activates Notch-1 signaling and induces apoptosis in medullary thyroid carcinoma cells.
    Ning L; Greenblatt DY; Kunnimalaiyaan M; Chen H
    Oncologist; 2008 Feb; 13(2):98-104. PubMed ID: 18305053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resveratrol induces Notch2-mediated apoptosis and suppression of neuroendocrine markers in medullary thyroid cancer.
    Truong M; Cook MR; Pinchot SN; Kunnimalaiyaan M; Chen H
    Ann Surg Oncol; 2011 May; 18(5):1506-11. PubMed ID: 21184191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MK-2206 causes growth suppression and reduces neuroendocrine tumor marker production in medullary thyroid cancer through Akt inhibition.
    Burke JF; Schlosser L; Harrison AD; Kunnimalaiyaan M; Chen H
    Ann Surg Oncol; 2013 Nov; 20(12):3862-8. PubMed ID: 23900743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valproic acid activates Notch1 signaling and induces apoptosis in medullary thyroid cancer cells.
    Greenblatt DY; Cayo MA; Adler JT; Ning L; Haymart MR; Kunnimalaiyaan M; Chen H
    Ann Surg; 2008 Jun; 247(6):1036-40. PubMed ID: 18520232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suberoyl bishydroxamic acid inhibits cellular proliferation by inducing cell cycle arrest in carcinoid cancer cells.
    Greenblatt DY; Cayo M; Ning L; Jaskula-Sztul R; Haymart M; Kunnimalaiyaan M; Chen H
    J Gastrointest Surg; 2007 Nov; 11(11):1515-20; discussion 1520. PubMed ID: 17874277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis-mediated medullary thyroid cancer growth suppression by the PI3K inhibitor LY294002.
    Kunnimalaiyaan M; Ndiaye M; Chen H
    Surgery; 2006 Dec; 140(6):1009-14; discussion 1014-5. PubMed ID: 17188151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of the NOTCH1 intracellular domain inhibits cell proliferation and alters the neuroendocrine phenotype of medullary thyroid cancer cells.
    Kunnimalaiyaan M; Vaccaro AM; Ndiaye MA; Chen H
    J Biol Chem; 2006 Dec; 281(52):39819-30. PubMed ID: 17090547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chrysin activates Notch1 signaling and suppresses tumor growth of anaplastic thyroid carcinoma in vitro and in vivo.
    Yu XM; Phan T; Patel PN; Jaskula-Sztul R; Chen H
    Cancer; 2013 Feb; 119(4):774-81. PubMed ID: 22991264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the active Notch1 decreases MTC tumor growth in vivo.
    Jaskula-Sztul R; Pisarnturakit P; Landowski M; Chen H; Kunnimalaiyaan M
    J Surg Res; 2011 Nov; 171(1):23-7. PubMed ID: 21571316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suberoyl bis-hydroxamic acid activates Notch1 signaling and induces apoptosis in anaplastic thyroid carcinoma through p53.
    Li J; Zheng X; Gao M; Zhao J; Li Y; Meng X; Qian B; Li J
    Oncol Rep; 2017 Jan; 37(1):458-464. PubMed ID: 28004113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chrysin suppresses achaete-scute complex-like 1 and alters the neuroendocrine phenotype of carcinoids.
    Somnay YR; Dull BZ; Eide J; Jaskula-Sztul R; Chen H
    Cancer Gene Ther; 2015 Oct; 22(10):496-505. PubMed ID: 26403073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of glycogen synthase kinase-3beta, a downstream target of the raf-1 pathway, is associated with growth suppression in medullary thyroid cancer cells.
    Kunnimalaiyaan M; Vaccaro AM; Ndiaye MA; Chen H
    Mol Cancer Ther; 2007 Mar; 6(3):1151-8. PubMed ID: 17363508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leflunomide suppresses growth in human medullary thyroid cancer cells.
    Alhefdhi A; Burke JF; Redlich A; Kunnimalaiyaan M; Chen H
    J Surg Res; 2013 Nov; 185(1):212-6. PubMed ID: 23816245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of growth in medullary thyroid cancer cells with histone deacetylase inhibitors and lithium chloride.
    Adler JT; Hottinger DG; Kunnimalaiyaan M; Chen H
    J Surg Res; 2010 Apr; 159(2):640-4. PubMed ID: 19394967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyper-activation of WNT/β-catenin signaling pathway mediates anti-tumor effects of histone deacetylase inhibitors in acute T lymphoblastic leukemia.
    Shao N; Zou J; Li J; Chen F; Dai J; Qu X; Sun X; Ma D; Ji C
    Leuk Lymphoma; 2012 Sep; 53(9):1769-78. PubMed ID: 22303878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suberoyl bishydroxamic acid inhibits the growth of A549 lung cancer cells via caspase-dependent apoptosis.
    You BR; Park WH
    Mol Cell Biochem; 2010 Nov; 344(1-2):203-10. PubMed ID: 20652372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortalin (GRP75/HSPA9) upregulation promotes survival and proliferation of medullary thyroid carcinoma cells.
    Starenki D; Hong SK; Lloyd RV; Park JI
    Oncogene; 2015 Aug; 34(35):4624-34. PubMed ID: 25435367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone deacetylase inhibitor suberoyl bis-hydroxamic acid suppresses cell proliferation and induces apoptosis in breast cancer cells.
    Yang X; Zhang N; Shi Z; Yang Z; Hu X
    Mol Med Rep; 2015 Apr; 11(4):2908-12. PubMed ID: 25501628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fisetin induces G2/M phase arrest and caspase-mediated cleavage of p21
    Yadav M; Kandhari K; Mathan SV; Ali M; Singh RP
    Mol Carcinog; 2024 Sep; 63(9):1697-1711. PubMed ID: 38801393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.